research chemical is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-09. Numbers and descriptions here follow the published literature rather than marketing material.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
== N == Nametkin rearrangement Narasaka–Prasad reduction Nazarov cyclization reaction Neber rearrangement Nef reaction Negishi coupling Negishi zipper reaction Nenitzescu indole synthesis Nenitzescu reductive acylation Newman–Kwart rearrangement Nicholas reaction Niementowski quinazoline synthesis Niementowski quinoline synthesis Nierenstein reaction NIH shift Ninhydrin test Nitroaldol reaction Nitrone-olefin 3+2 cycloaddition Normant reagents Noyori asymmetric hydrogenation Nozaki–Hiyama–Kishi reaction Nucleophilic acyl substitution
Prazosin, sold under the brand name Minipress among others, is a medication used to treat high blood pressure, symptoms of an enlarged prostate, and nightmares related to post-traumatic stress disorder (PTSD). It is an α1 blocker. It is a less preferred treatment of high blood pressure. Other uses may include heart failure and Raynaud syndrome. It is taken by mouth. Common side effects include dizziness, sleepiness, nausea, and heart palpitations. Serious side effects may include low blood pressure with standing and depression. Prazosin is a non-selective inverse agonist of the α1-adrenergic receptors. It works to decrease blood pressure by dilating blood vessels and helps with an enlarged prostate by relaxing the outflow of the bladder. How it works in PTSD is not entirely clear. Prazosin was patented in 1965 and came into medical use in 1974. It is available as a generic medication. In 2021, it was the 183rd most commonly prescribed medication in the United States, with more than 2 million prescriptions.
==== Oral testosterone ==== Testosterone is well-absorbed but extensively metabolized with oral administration due to the first pass through the intestines and liver. It is rapidly and completely inactivated in men at doses of less than 200 mg. In large doses, such as 200 mg however, significant increases in circulating testosterone levels become apparent. In addition, while a 60 mg dose has no effect on testosterone levels in men, this dose does measurably increase testosterone levels in prepubertal boys and women. The oral bioavailability of testosterone in young women after a single 25 mg dose was found to be 3.6 ± 2.5%. High levels of testosterone are also achieved with a 60 mg dose of oral testosterone in men with liver cirrhosis. These findings are attributed to induction of liver enzymes by testosterone and consequent activation of its own metabolism. Substitution dosages of oral testosterone in men are in the range of 400 to 800 mg/day. Such doses exceed the amount of testosterone produced by the body, which is approximately 7 mg/day, by approximately 100-fold. The elimination half-life of oral testosterone is rapid at about 5 to 7 hours. As a result, it requires administration several times per day in divided doses. Due to its limitations, such as the high doses required and necessity of multiple daily doses, oral testosterone is not used clinically in its unmodified form. Oral testosterone has been studied in combination with a 5α-reductase inhibitor to reduce its first-pass metabolism and improve its bioavailability.
Management of obesity can include lifestyle changes, medications, or surgery. Although many studies have sought effective interventions, there is currently no evidence-based, well-defined, and efficient intervention to prevent obesity. Treatment for obesity often consists of weight loss via healthy nutrition and increasing physical exercise. A 2007 review concluded that certain subgroups, such as those with type 2 diabetes and women who undergo weight loss, show long-term benefits in all-cause mortality, while long‐term outcomes for men are "not clear and need further investigation." The most effective treatment for obesity is bariatric surgery. Surgery for severe obesity is associated with long-term weight loss and decreased overall mortality. One study found a weight loss of between 14% and 25% (depending on the type of procedure performed) at 10 years, and a 29% reduction in all cause mortality when compared to standard weight loss measures. Another study also found reduced mortality in those who underwent bariatric surgery for severe obesity. Diet programs can produce short-term weight loss and, to a lesser extent, over the long-term. Greater weight loss results, including amongst underserved populations, are achieved when proper nutrition is regularly combined with physical exercise and counseling. Dietary and lifestyle changes are effective in limiting excessive weight gain in pregnancy and improve outcomes for both the mother and the child.
== K == K-complex A large, slow wave seen in EEG during stage 2 of non-REM sleep. It is involved in memory consolidation and sensory processing during sleep. Kainate receptor A subtype of ionotropic glutamate receptor involved in fast excitatory synaptic transmission. Kainate receptors play roles in learning and are implicated in seizure disorders. Kallmann syndrome A genetic condition characterized by delayed or absent puberty and an impaired sense of smell. It results from disrupted migration of olfactory and gonadotropin-releasing hormone neurons. Karyokinesis The process of nuclear division during cell division. In the context of developmental neuroscience, it describes how neural progenitor cells divide in the developing brain. Karyotype A visual profile of an organism’s chromosomes. In neuroscience, used in research or diagnostics for identifying chromosomal abnormalities linked to neurodevelopmental disorders. Kelvin–Voigt model A viscoelastic model used in computational neuroscience and biomechanics to describe tissue deformation, including brain tissue mechanics. Keratitis Inflammation of the cornea, which may be linked to neural dysfunction in the trigeminal nerve or autonomic nervous system regulation. Kinesthesia The sense of limb and body movement, closely related to proprioception. It is mediated by mechanoreceptors in muscles and joints and processed in the somatosensory cortex. Kindling A process by which repeated sub-threshold electrical or chemical stimulation of the brain leads to progressively more intense seizures. Used as a model for epilepsy.
Sources: en.wikipedia.org
== Cited literature == Bilstein, Roger E. (1996). Stages to Saturn: A Technological History of the Apollo/Saturn Launch Vehicles. Washington: Scientific and Technical Information Branch, National Aeronautics and Space Administration. ISBN 0-16-048909-1. Burgess, Colin; Hall, Rex (2009). The First Soviet Cosmonaut Team. Chichester, UK: Praxis Publishing. ISBN 978-0-387-84824-2. LCCN 2008935694. Burgess, Colin; Kate Doolan; Bert Vis (2003). Fallen Astronauts: Heroes Who Died Reaching for the Moon. Lincoln: University of Nebraska Press. ISBN 0-8032-6212-4. Brzezinski, Matthew (2007). Red Moon Rising: Sputnik and the Hidden Rivalries that Ingnited the Space Race. New York: Times Books, Henry Holt and Company. ISBN 978-0-8050-8147-3. Burrows, William E. (1998). This New Ocean: The Story of the First Space Age. New York: Random House. ISBN 978-0-679-44521-0. Cadbury, Deborah (2006). Space Race: The Epic Battle Between America and the Soviet Union for Dominance of Space. New York: Harper Collins Publishers. ISBN 978-0-06-084553-7. Chaikin, Andrew (1994). A Man on the Moon: The Triumphant Story of the Apollo Space Program. New York: Penguin Books. ISBN 0-14-027201-1. Chertok, Boris (2005). Rockets and People Volumes 1-4. National Aeronautics and Space Administration. Retrieved May 29, 2022. Cornwell, John (2003). Hitler's Scientists: Science, War, and the Devil's Pact. New York: Viking Press. ISBN 0-670-03075-9. Dallek, Robert (2003). An Unfinished Life: John F. Kennedy, 1917–1963. Boston: Little, Brown and Company. ISBN 0-316-17238-3. Leonard, David (2019). Moon Rush.
==== Convergent evolution ==== Color change is widespread in ectotherms including anoles, frogs, mollusks, many fish, insects, and spiders. The mechanism behind this color change can be either morphological or physiological. Morphological change is the result of a change in the density of pigment containing cells and tends to change over longer periods of time. Physiological change, the kind observed in cephalopod lineages, is typically the result of the movement of pigment within the chromatophore, changing where different pigments are localized within the cell. This physiological change typically occurs on much shorter timescales compared to morphological change. Cephalopods have a rare form of physiological color change which utilizes neural control of muscles to change the morphology of their chromatophores. This neural control of chromatophores has evolved convergently in both cephalopods and teleosts fishes.
== Education == The prevalence of stepfamilies has increased over the past century with the increase of divorce and remarriage. According to the Step Family Foundation, "over 50% of US families are remarried or recoupled." These families are unique in their experiences facing many challenges which first-married families do not. For example, role ambiguity, dealing with stepchildren, and ex-spouses are only a few of the issues which are unique to these families. In response to these families' desire for assistance, stepfamily education has become an increasingly common topic among scholars and educators. Although still a relatively new facet within the marriage education realm, stepfamily education provides important information which may not be addressed in traditional marriage or relationship education curriculum. As discussed by Adler-Baeder and Higginbotham (2004) a number of curricula are currently available to stepfamilies and family life educators; however, further research is needed in order to determine best practices for the field. One way in which this gap is being filled is through the current implementation of Healthy Marriage Demonstration Grants in the U.S. As part of the Deficit Reduction Act of 2005, grants for healthy marriage and responsible fatherhood, which include at-risk and diverse populations such as stepfamilies, are providing important information on the evaluation of stepfamily programs and their effectiveness in servicing stepfamilies.
The Oddo–Harkins rule holds that elements with even atomic numbers are more common than those with odd atomic numbers, with the exception of hydrogen and beryllium. This rule argues that elements with odd atomic numbers have one unpaired proton and are more likely to capture another, thus increasing their atomic number. In elements with even atomic numbers, protons are paired, with each member of the pair offsetting the spin of the other, enhancing stability. All the alkali metals have odd atomic numbers and they are not as common as the elements with even atomic numbers adjacent to them (the noble gases and the alkaline earth metals) in the Solar System. The heavier alkali metals are also less abundant than the lighter ones as the alkali metals from rubidium onward can only be synthesised in supernovae and not in stellar nucleosynthesis. Lithium is also much less abundant than sodium and potassium as it is poorly synthesised in both Big Bang nucleosynthesis and in stars: the Big Bang could only produce trace quantities of lithium, beryllium and boron due to the absence of a stable nucleus with 5 or 8 nucleons, and stellar nucleosynthesis could only pass this bottleneck by the triple-alpha process, fusing three helium nuclei to form carbon, and skipping over those three elements.
=== Australia === Absinthe is readily available in many bottle shops. Bitters may contain a maximum 35 mg/kg thujone, while other alcoholic beverages can contain a maximum 10 mg/kg. The domestic production and sale of absinthe is regulated by state licensing laws.
Sources: en.wikipedia.org
Many mushroom species produce secondary metabolites that can be toxic, mind-altering, antibiotic, antiviral, or bioluminescent. Although there are only a small number of deadly species, several others can cause particularly severe and unpleasant symptoms. Toxicity likely plays a role in protecting the function of the basidiocarp: the mycelium has expended considerable energy and protoplasmic material to develop a structure to efficiently distribute its spores. One defense against consumption and premature destruction is the evolution of chemicals that render the mushroom inedible, either causing the consumer to vomit the meal (see emetics), or to learn to avoid consumption altogether. In addition, due to the propensity of mushrooms to absorb heavy metals, including those that are radioactive, as late as 2008, European mushrooms may have included toxicity from the 1986 Chernobyl disaster and have continued to be studied.
Zoltan Galántai recognizes the important role that Kardashev's classification has played in the SETI program, but he believes that another scale is possible, without using energy consumption, by resorting to miniaturization. The hypothesis of Donald Tarter, researcher at SETI, is that a civilization based on nanotechnology would not need an ever-increasing amount of energy. A Type I civilization that masters local space travel could colonize its planetary system and even the Oort cloud without needing an amount of energy that would make it Type II. This scale loses its meaning beyond Type II, since it is impossible to predict the evolution of civilizations over long distances in a galactic colonization process. Finally, Tarter states that the Kardashev scale is the product of an era of insufficient scientific knowledge, which considered the possibility of stellar object CTA-102 as an artificial Type III source, whereas today we know that it is a galactic nucleus. In another article, Zoltan Galántai suggests considering another scale, no longer based on energy consumption, but on a civilization's ability to survive natural and cosmic disasters. Type I would describe a civilization capable of surviving a local natural disaster, like the Anasazi. A Type II civilization would have the means to withstand a regional or continental disaster, and finally Type III could face a global disaster such as an asteroid's impact, a supervolcano's eruption, or an ice age. Beyond the first three types are civilizations that have scattered throughout the galaxy.
== Chemistry and biology == Collagen hybridizing peptide CHP (gene) Chp (GTPase) Cumene hydroperoxide Capillary hydrostatic pressure, a component of the Starling equation N-cyclohexyl-2-pyrrolidone (liquid solvent) Chemical formula of Methylidynephosphane
== FSH analogues == Corifollitropin alfa Merck received approval on February 15, 2010, from the European Commission for ELONVA (corifollitropin alfa) a long lasting single injection fusion protein lacking LH activity. Only one injection is required for the first seven days, replacing the first seven daily injections of conventional FSH. Initial results demonstrates similar pregnancy rates as daily recombinant FSH injections.
20–30, 1991 Salgues, E., "Naram-Sin's conquests of Subartu and Armanum", Akkade is King. A collection of papers by friends and colleagues presented to Aage Westenholz on the occasion of his 70th birthday 15 May 2009, hrsg. v. Gojko Barjamovic (Uitgaven van het Nederlands Instituut voor het Nabije Oosten te Leiden 118), pp. 253–272, 2011 Steinkeller, Piotr, "The Roundlet of Naram-Suen", History, Texts and Art in Early Babylonia: Three Essays, Berlin, Boston: De Gruyter, pp. 158–164, 2017 F.Thureau-Dangin, Une inscription de Naram-Sin", Revue d’Assyriologie et d’archéologie Orientale, vol. 8, no. 4, pp. 199–200, 1911
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.